management control of IRSL in April 2019, IRSL operational and financial performance has been improving. IVL has appointed a new management team, including the CEO and CFO, in IRSL to manage and operate the
profit was 2.42%, increased from last year at net loss 2.39%. The main factor is the control of production costs, improving the gross margin and control costs of selling and administrative. Panjawattana
%, representing gross profit margin of 38.9%, an increase from 32.0% gross profit margin in the corresponding period last year, mainly due to the improving margins for the branded products by the Company’s
percent. The Company’s net profit margin stood at 27.7 percent. An increase of net profit was a result of the Company has higher revenues from collection of purchased accounts receivables and debt tracking
Purchase of Receivables (Expected payment exceeding 1 year) which mainly was the bad debt purchased from financial institutions. Management Discussion and Analysis (MD&A) 2019 Page 5/6 Liabilities As of 31
purchased from Global Inspired Laboratory Co., Ltd. Date of transaction : Within February 2018 Buyer : Bangkok Chain Hospital PCL. Seller : Global Inspired Laboratory Co., Ltd. Relationship with the
: Approval of Asset purchased from Global Inspired Laboratory Co., Ltd. Date of transaction : Within February 2018 Buyer : Bangkok Chain Hospital PCL. Seller : Global Inspired Laboratory Co., Ltd
higher revenues from collection of purchased accounts receivables and debt tracking services. For 9-months period of 2018, the Company’s net profit was 374.3 million baht which increased 26.1 percent from
Concerning the Acquisition and Disposal of Assets B.E. 2547 ; therefore the company would like to inform the information of the said transaction as follows: 1. Transaction Date The company purchased shares in
previous quarter of the same year and the corresponding financial period in 2020. This information had a positive impact on SVI’s stock price. Mr. Pongsak Lothongkam had purchased SVI shares before SVI